Phage-Derived Depolymerase: Its Possible Role for Secondary Bacterial Infections in COVID-19 Patients

Phage-Derived Depolymerase: Its Possible Role for Secondary Bacterial Infections in COVID-19 Patients

As of 29 July 2022, there had been a cumulative 572,239,451 confirmed cases of COVID-19 worldwide, including 6,390,401 fatalities. COVID-19 patients with severe symptoms are usually treated with a combination of virus- and drug-induced immuno-suppression medicines. Critical clinical complications of...

Full description

Bibliographic Details
Main Authors: Amina Nazir, Jiaoyang Song, Yibao Chen, Yuqing Liu
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Microorganisms
Subjects:
COVID-19
antivirulent agents
bacteriophage
depolymerase
Online Access:https://www.mdpi.com/2076-2607/11/2/424

Similar Items

Similar Items